J B CHEMICALS AND PHARMA vs TORRENT PHARMACEUTICALS L

A side-by-side comparison of J B CHEMICALS AND PHARMA (JBCHEPHARM) and TORRENT PHARMACEUTICALS L (TORNTPHARM) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

J B CHEMICALS AND PHARMA and TORRENT PHARMACEUTICALS L are evenly matched on the numbers (77). The breakdown below shows where each one wins.

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

54.51
P/E ratio
74.52
8.96
P/B ratio
19.76
0.90%
Dividend yield
0.78%
₹44.19
EPS
₹63.92

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

18.90%
Return on equity
27.40%
25.00%
Return on capital
15.00%
27.00%
EBITDA margin
33.00%
17.09%
Net margin
15.29%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

9.62%
Revenue CAGR (3Y)
13.27%
20.03%
Profit CAGR (3Y)
19.75%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹38,676 Cr
Market cap
₹1.61L Cr
₹4,148 Cr
Revenue
₹13,980 Cr
₹709 Cr
Net profit
₹2,138 Cr
0.00
Debt / equity
1.79
J B CHEMICALS AND PHARMA
  • + ["Company has reduced debt.", "Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 40.3%", "Promoter holding has increased by 1.25% over last quarter."]
  • ["Stock is trading at 9.40 times its book value", "Promoter holding has decreased over last 3 years: -5.13%", "Working capital days have increased from 86.6 days to 126 days"]
TORRENT PHARMACEUTICALS L
  • + ["Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%", "Company has been maintaining a healthy dividend payout of 57.8%"]
  • ["Stock is trading at 19.8 times its book value", "The company has delivered a poor sales growth of 11.8% over past five years.", "Company might be capitalizing the interest cost"]
J B CHEMICALS AND PHARMA full analysis TORRENT PHARMACEUTICALS L full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.